Evaluating the Safety and Efficacy of Telemedicine Physician Assessments on a Mobile Stroke Unit: Protocol for a Prospective Open-Label Blinded End-Point Randomized Controlled Trial.

mobile stroke unit prehospital stroke telemedicine trial design

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
18 Oct 2024
Historique:
medline: 19 10 2024
pubmed: 19 10 2024
entrez: 18 10 2024
Statut: aheadofprint

Résumé

Mobile stroke units have been shown to deliver faster patient care and improve clinical outcomes. However, costs associated with staffing limit their use to densely populated cities. Using the Melbourne mobile stroke unit, we aim to evaluate the safety, timeliness, and resource efficiency of a telemedicine model, where the neurologist assesses a patient remotely, via telemedicine, compared with an onboard neurologist model. We hypothesize that, without compromising patient safety, the telemedicine model will provide timely care and superior resource efficiency. Using a prospective, randomized, blinded end-point controlled design, 270 participants consecutively assessed on the Melbourne mobile stroke unit over ≈12 months will be assigned into 2 arms: (1) telemedicine neurologist assessment (intervention) versus (2) onboard assessment (comparator). Enrollment is based on prospectively designated randomized days of neurologist review onboard versus telemedicine. The primary outcome will be the odds that a randomly selected participant in the telemedicine arm will have a better outcome than a randomly selected participant in the onboard arm, measured using a desirability-of-outcome ranking, an outcome measure that includes, in order of importance: (1) safety, (2) scene-to-treatment-decision time metrics, and (3) resource usage. All participants within each arm will be compared with those in the other, resulting in a "win/tie/loss" distribution for telemedicine compared with the onboard model. The study will establish whether use of a telemedicine neurologist delivers superior resource efficiency without compromising patient care. This would enable the broader use of mobile stroke units, particularly relevant to regions with limited access to neurologists, thus improving equity in access to time-critical, lifesaving stroke care. URL: clinicaltrials.gov; Unique Identifier: NCT05991310.

Sections du résumé

BACKGROUND BACKGROUND
Mobile stroke units have been shown to deliver faster patient care and improve clinical outcomes. However, costs associated with staffing limit their use to densely populated cities. Using the Melbourne mobile stroke unit, we aim to evaluate the safety, timeliness, and resource efficiency of a telemedicine model, where the neurologist assesses a patient remotely, via telemedicine, compared with an onboard neurologist model. We hypothesize that, without compromising patient safety, the telemedicine model will provide timely care and superior resource efficiency.
METHODS METHODS
Using a prospective, randomized, blinded end-point controlled design, 270 participants consecutively assessed on the Melbourne mobile stroke unit over ≈12 months will be assigned into 2 arms: (1) telemedicine neurologist assessment (intervention) versus (2) onboard assessment (comparator). Enrollment is based on prospectively designated randomized days of neurologist review onboard versus telemedicine. The primary outcome will be the odds that a randomly selected participant in the telemedicine arm will have a better outcome than a randomly selected participant in the onboard arm, measured using a desirability-of-outcome ranking, an outcome measure that includes, in order of importance: (1) safety, (2) scene-to-treatment-decision time metrics, and (3) resource usage. All participants within each arm will be compared with those in the other, resulting in a "win/tie/loss" distribution for telemedicine compared with the onboard model.
CONCLUSIONS CONCLUSIONS
The study will establish whether use of a telemedicine neurologist delivers superior resource efficiency without compromising patient care. This would enable the broader use of mobile stroke units, particularly relevant to regions with limited access to neurologists, thus improving equity in access to time-critical, lifesaving stroke care.
REGISTRATION BACKGROUND
URL: clinicaltrials.gov; Unique Identifier: NCT05991310.

Identifiants

pubmed: 39424402
doi: 10.1161/JAHA.124.036856
doi:

Banques de données

ClinicalTrials.gov
['NCT05991310']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036856

Investigateurs

Chloe Mutimer (C)
James Barker (J)
Angela Dos Santos (AD)
Jo Lyn Ng (JL)
Felix Ng (F)
Bernard Yan (B)
Margaret Ma (M)
Joey Wong (J)
Ashley Park (A)
Angelos Sharobeam (A)
Michael Valente (M)
Cameron Williams (C)
Stan Ho (S)
Patrick Scarff (P)
Cassandra Beltrame (C)
Christine Shin (C)
Vincent Thijs (V)
John Fink (J)
Alan Barber (A)
Longting Lin (L)

Auteurs

Vignan Yogendrakumar (V)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.
Division of Neurology (Department of Medicine), The Ottawa Hospital and The Ottawa Hospital Research Institute University of Ottawa Ottawa Canada.

Anna H Balabanski (AH)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.
Department of Neuroscience School of Translational Medicine and Alfred Health Melbourne Australia.

Hannah Johns (H)

Department of Medicine, Melbourne Medical School University of Melbourne Australia.

Leonid Churilov (L)

Department of Medicine, Melbourne Medical School University of Melbourne Australia.

Nicola K Parsons (NK)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

James Beharry (J)

Department of Neurology Christchurch Hospital Christchurch New Zealand.

Louise Weir (L)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Nawaf Yassi (N)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.
Population Health and Immunity Division The Walter and Eliza Hall Institute of Medical Research Melbourne Australia.

Henry Zhao (H)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Alex Warwick (A)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.
Department of Neurology Austin Hospital Melbourne Australia.

Skye Coote (S)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Francesca Langenberg (F)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Leigh Branagan (L)

Ambulance Victoria Melbourne Australia.

Wasseem Siddiqi (W)

Ambulance Victoria Melbourne Australia.

Andrew Bivard (A)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Bruce C V Campbell (BCV)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Geoffrey A Donnan (GA)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Stephen M Davis (SM)

Department of Neurology, University of Melbourne Melbourne Brain Centre at the Royal Melbourne Hospital Melbourne Australia.

Classifications MeSH